Background: Omenn syndrome (OS) is an autosomal-recessive disorder characterized by severe immunodeficiency and T-cell-mediated autoimmunity. The disease is caused by hypomorphic mutations in recombination-activating genes that hamper the process of Variable (V) Diversity (D) Joining (J) recombination, leading to the generation of autoreactive T cells. We have previously shown that in OS the expression of autoimmune regulator, a key factor governing central tolerance, is markedly reduced. Objective: Here, we have addressed the role of peripheral tolerance in the disease pathogenesis. Methods: We have analyzed forkhead box protein P3 (FOXP3) expression in peripheral blood T cells of 4 patients with OS and in lymphoid organs of 8 patients with OS and have tested the suppressive activity of sorted CD4+ CD25high peripheral blood T cells in 2 of these patients. Results: We have observed that CD4+CD25highT cells isolated ex vivo from patients with OS failed to suppress proliferation of autologous or allogenic CD4+ responder T cells. Moreover, despite individual variability in the fraction of circulating FOXP3+ CD4 cells in patients with OS, the immunohistochemical analysis of FOXP3 expression in lymph nodes and thymus of patients with OS demonstrated a severe reduction of this cell subset compared with control tissues. Conclusion: Overall, these results suggest a defect of regulatory T cells in OS leading to a breakdown of peripheral tolerance, which may actively concur to the development of autoimmune manifestations in the disease.

Defect of regulatory T cells in patients with Omenn syndrome / B. Cassani, L. Poliani, D. Moratto, C. Sobacchi, V. Marrella, L. Imperatori, D. Vairo, A. Plebani, S. Giliani, F. Facchetti, F. Porta, L.D. Notarangelo, A.V.A.R. Badolato. - In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 0091-6749. - 125:1(2010), pp. 209-216. [10.1016/j.jaci.2009.10.023]

Defect of regulatory T cells in patients with Omenn syndrome

B. Cassani;F. Facchetti;
2010

Abstract

Background: Omenn syndrome (OS) is an autosomal-recessive disorder characterized by severe immunodeficiency and T-cell-mediated autoimmunity. The disease is caused by hypomorphic mutations in recombination-activating genes that hamper the process of Variable (V) Diversity (D) Joining (J) recombination, leading to the generation of autoreactive T cells. We have previously shown that in OS the expression of autoimmune regulator, a key factor governing central tolerance, is markedly reduced. Objective: Here, we have addressed the role of peripheral tolerance in the disease pathogenesis. Methods: We have analyzed forkhead box protein P3 (FOXP3) expression in peripheral blood T cells of 4 patients with OS and in lymphoid organs of 8 patients with OS and have tested the suppressive activity of sorted CD4+ CD25high peripheral blood T cells in 2 of these patients. Results: We have observed that CD4+CD25highT cells isolated ex vivo from patients with OS failed to suppress proliferation of autologous or allogenic CD4+ responder T cells. Moreover, despite individual variability in the fraction of circulating FOXP3+ CD4 cells in patients with OS, the immunohistochemical analysis of FOXP3 expression in lymph nodes and thymus of patients with OS demonstrated a severe reduction of this cell subset compared with control tissues. Conclusion: Overall, these results suggest a defect of regulatory T cells in OS leading to a breakdown of peripheral tolerance, which may actively concur to the development of autoimmune manifestations in the disease.
No
English
anergy and tolerance; FOXP3; Immunodeficiency; Omenn syndrome; regulatory T cells; thymus and the development of T lymphocytes; V(D)J recombination
Settore BIO/17 - Istologia
Articolo
Esperti anonimi
Pubblicazione scientifica
2010
125
1
209
216
8
Pubblicato
Periodico con rilevanza internazionale
miur
MIUR-MANUAL
Aderisco
info:eu-repo/semantics/article
Defect of regulatory T cells in patients with Omenn syndrome / B. Cassani, L. Poliani, D. Moratto, C. Sobacchi, V. Marrella, L. Imperatori, D. Vairo, A. Plebani, S. Giliani, F. Facchetti, F. Porta, L.D. Notarangelo, A.V.A.R. Badolato. - In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 0091-6749. - 125:1(2010), pp. 209-216. [10.1016/j.jaci.2009.10.023]
reserved
Prodotti della ricerca::01 - Articolo su periodico
13
262
Article (author)
Periodico con Impact Factor
B. Cassani, L. Poliani, D. Moratto, C. Sobacchi, V. Marrella, L. Imperatori, D. Vairo, A. Plebani, S. Giliani, F. Facchetti, F. Porta, L.D. Notarangel...espandi
File in questo prodotto:
File Dimensione Formato  
JACI 2010.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.18 MB
Formato Adobe PDF
1.18 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/921541
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 74
  • ???jsp.display-item.citation.isi??? 61
  • OpenAlex ND
social impact